- Supported exchanges /
- LSE /
- 0H8E.LSE
Accelerate Diagnostics Inc. (0H8E LSE) stock market data APIs
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was incorporated in 1982 and is headquartered in Tucson, Arizona.
Accelerate Diagnostics Inc. Financial Data Overview
| 1.54 | |
| 1.5628 | |
| - | |
| 1.5628 | |
| 1.54 | |
| 0.8518-6.84 | |
| 11 523 M | |
| 54 145 K | |
| 12 233 K | |
| -0.5026 | |
| 0.621 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Accelerate Diagnostics Inc. Fundamental Data is available in our Financial Data APIs
- Net Revenue 12 233 K
- EBITDA -40 770 000
- Earnings Per Share -1.056
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Accelerate Diagnostics Inc. Earnings via APIs
- Latest Release 2024-08-08
- EPS/Forecast NaN
Get Accelerate Diagnostics Inc. End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
